Atara biotherapeutics to present data at the 2021 transplantation & cellular therapy meeting digital experience

South san francisco, calif.--(business wire)--atara biotherapeutics, inc. (nasdaq: atra), a pioneer in t-cell immunotherapy, leveraging its novel allogeneic ebv t-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the company will present data in the form of six poster presentations at the transplantation & cellular therapy (tct) meeting of the american society for transpla
ATRA Ratings Summary
ATRA Quant Ranking